Theranos and compliance
One of the most compelling business stories over the past 18 months or so has been that of the Theranos, the developer of a perhaps revolutionary blood testing system, which allegedly allow testing of blood with such a small amount a person would only need their finger pricked. No longer ...
Related articles
-
Article
LendingClub could teach Theranos a thing or two about crisis management
Relatively young, technology-based companies face special difficulties when dealing with crises. Their focus on market disruption and their lack of established credibility make earning public trust even more difficult. And yet, LendingClub shows how it can be done at a time when Theranos certainly failed the crisis management test. David ...
-
WebcastCPE Webcast: How to Build Holistic Risk and Resilience Management
Risk, compliance, and business continuity teams often run in parallel, but what if they worked better together? As risks become more interconnected and the pressure to respond quickly grows, companies are realizing that a siloed approach doesn’t cut it anymore.
-
WebcastCPE Webcast: Risky Business: Navigating Compliant Innovation Amid Deregulation
The compliance landscape has entered unprecedented territory, characterized by what industry experts describe as “deregulation on top of deregulation” – a dangerous departure from the traditional regulatory cycle that historically provided stability and clear guidance.